Chinese biotech bgi will pass huawei in scale and threat, says sen Ndaa package revives stalled measures on us outbound investment and biotech, signalling capitol hill’s hardened stance towards beijing. 'it's terrifying,' he said at cnbc event, pushing for more corporate spying.
China has pulled ahead of the united states in key areas of the life sciences, and the u.s Congressional commission has made the case for “swift action” to maintain the nation’s role as a biotech superpower, while warning the sector is “dangerously close to falling behind. May only have a handful of years to regain dominance in the sector, according to an independent.
Risks falling behind permanently unless it takes action over the next three years, a congressional commission said.
